Health Care & Regulated Industries
Ulmer’s Health Care & Regulated Industries Group helps our clients navigate the industry’s vast and changing regulatory environment, while remaining focused on their ultimate business objectives. Our depth of health care knowledge and experience proves vital in helping our clients compete in this challenging industry.
We represent a wide-variety of health care clients, including hospitals, health systems, retail pharmacies, single and multi-specialty physician groups, emergency and hospitalist staffing companies, billing companies, preferred provider organizations, management service organizations, physician hospital organizations, clinics, long term care facilities, laboratories, pharmaceutical and durable medical equipment suppliers, and other entities in the health care field.
We assist clients in structuring and conducting business relationships–including acquisitions, investments, and joint ventures—in accordance with federal and state physician self-referral laws, anti-kickback laws, false claims laws, and other applicable guidelines. Beyond our regulatory and transactional services, our multi-disciplinary team assists health care stakeholders with an array of legal issues impacting their business, including labor and employment, insurance, HIPAA, privacy, tax, and corporate governance matters.
In addition to these traditional health care matters, our industry group advises clients on emerging issues in the ever-changing health care space including, for example, providing counsel to our clients on a broad range of medical marijuana related matters as the industry evolves. We leverage our regulatory experience and business acumen to plan for and promote the long-term success of our clients, helping them keep pace with changing laws, comply with current regulations and achieve their underlying business goals.
The Centers for Medicare & Medicaid Services (CMS) and the Department of Health and Human Services Office of the Inspector General (OIG) issued two highly anticipated (and extensive) final rules to reform the Stark Law and Anti-Kickback Statute (AKS) regulations. These rule changes and clarifications are aimed at removing regulatory...
November 23, 2020
Ohio Senate Bill 57 was signed into law by Governor Mike DeWine on July 30, 2019, legalizing the cultivation of hemp (with a license from the Ohio Department of Agriculture) and the immediate sale of cannabidiol (CBD) products in the state of Ohio. Until the passage of this bill, the...
August 05, 2019